# Pier Luigi Meroni

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pier-luigi-meroni/

## Facts

| Field | Value |
| --- | --- |
| Citations | 56,285 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 105 |
| i10-index | 557 |
| Last Known Institution | IRCCS Istituto Auxologico Italiano |
| OpenAlex ID | https://openalex.org/A5030466896 |
| ORCID iD | https://orcid.org/0000-0002-3394-1451 |
| Works | 1,026 |

## Researcher papers

Showing 12 of 14.

- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients](https://scholariq.org/papers/antiphospholipid-syndrome-clinical-and-immunologic-manifestations-and-patterns/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [EULAR recommendations for the management of antiphospholipid syndrome in adults](https://scholariq.org/papers/eular-recommendations-for-the-management-of-antiphospholipid-syndrome-in-adults/)
- [Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients](https://scholariq.org/papers/morbidity-and-mortality-in-the-antiphospholipid-syndrome-during-a-10-year-period/)
- [EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome](https://scholariq.org/papers/eular-recommendations-for-women-s-health-and-the-management-of-family-planning/)
- [Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases](https://scholariq.org/papers/accelerated-atherosclerosis-in-autoimmune-rheumatic-diseases/)
- [Anti-inflammatory and immunosuppressive drugs and reproduction.](https://scholariq.org/papers/anti-inflammatory-and-immunosuppressive-drugs-and-reproduction/)
- [The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria](https://scholariq.org/papers/the-2023-scp-acr-scp-scp-eular-scp-antiphospholipid-syndrome-classification/)
- [2023 ACR/EULAR antiphospholipid syndrome classification criteria](https://scholariq.org/papers/2023-acr-eular-antiphospholipid-syndrome-classification-criteria/)
- [Complement activation and endothelial perturbation parallel COVID-19 severity and activity](https://scholariq.org/papers/complement-activation-and-endothelial-perturbation-parallel-covid-19-severity/)
- [European consensus statement on the terminology used in the management of lupus glomerulonephritis](https://scholariq.org/papers/european-consensus-statement-on-the-terminology-used-in-the-management-of-lupus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [IRCCS Istituto Auxologico Italiano](https://scholariq.org/institutions/irccs-istituto-auxologico-italiano/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.